A general-purpose testing chamber with a documented next assignment differs from a custom prototype that has no use outside the failed project. Purchase price alone does not reveal that difference. Look for technical capability, approved future deployment, expected service period, and evidence that the asset survives the present experiment.
When the packet supports a later use, recognize and allocate the asset under the applicable model rather than charging its entire cost to the current R&D effort. Depreciation or other consumption attributable to current research can still enter R&D expense while the remaining service potential stays in the asset.
“We might reuse it” is not a control. A missing future-use schedule is a reason to request evidence, not to invent salvage value or postpone expense.
Apply the distinction
A testing chamber needs more than possible reuse. Technical capability, an approved later assignment, and supported remaining service can justify an asset while current-project depreciation remains R&D expense.
Authority
Read ASC 730-10-25-2 for the treatment of materials, equipment, facilities, and intangibles used in R&D.
Put the concept to work
Analyze this concept
- Distinguish a documented alternative future use from residual hope and allocate the supported asset amount between project consumption and later service.
Learning resources
Choose a lesson, try an application, or inspect the sources behind this concept.
Build on these ideas
- Research and development cost — Apply
To analyze this concept: Required. The alternative-use question arises only after the cost and R&D activity are identified.